- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neuroendocrine Tumors in Austria
Total 1205 results
-
Cooperative Research Centre for Biomedical Imaging...Unknown
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationCompletedMelanomaAustralia, United States
-
University Hospital HeidelbergGerman Cancer Research CenterRecruitingSolid Tumor | CNS TumorFrance, Germany, Australia, Austria, Sweden, Netherlands, Switzerland
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLCNot yet recruitingMucosal MelanomaAustralia
-
Melanoma Institute AustraliaNovartisRecruiting
-
Provectus PharmaceuticalsCompleted
-
QBiotics Group LimitedMerck Sharp & Dohme LLCTerminated
-
Novartis PharmaceuticalsCompletedPancreatic Neoplasms | Neuroendocrine Tumor | Neuroendocrine Carcinoma | Islet Cell CarcinomaUnited States, Canada, Spain, Argentina, Germany, Belgium, Italy, France, Sweden, Australia, Netherlands
-
Medical University of GrazUnknownLentigo MalignaAustria
-
ITM Solucin GmbHABX CRO; PSI CROActive, not recruitingNeuroendocrine TumorsGermany, France, United States, United Kingdom, Australia, Italy, Belgium, Switzerland, Czechia, Spain, Austria, Netherlands, Poland, South Africa
-
Novartis PharmaceuticalsCompletedPancreatic Neuroendocrine Tumors (pNET)France, Spain, Belgium, Germany, Italy, United Kingdom, Austria, Netherlands, United States
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruiting
-
Philogen S.p.A.Eudax S.r.l.TerminatedMetastatic MelanomaSwitzerland, Italy, Austria, Germany
-
QBiotics Group LimitedTerminated
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLC; NovartisActive, not recruiting
-
Bristol-Myers SquibbActive, not recruiting
-
Provectus PharmaceuticalsCompleted
-
Evaxion Biotech A/SMerck Sharp & Dohme LLCRecruitingMelanoma Stage IV | Melanoma Stage IIIAustralia
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLCActive, not recruitingMelanoma Stage IIIAustralia
-
Anthony Joshua, FRACPSt Vincent's Hospital, SydneyActive, not recruiting
-
ITM Solucin GmbHRecruitingNeuroendocrine TumorsUnited States, United Kingdom, Australia, Netherlands, France, Italy, Spain, Germany, Sweden, India
-
Paola Anna ErbaErasmus Medical Center; Jagiellonian University; Medical University Innsbruck; University... and other collaboratorsCompletedMedullary Thyroid CarcinomaAustria, Germany, Netherlands, Poland, Slovenia
-
InxMed (Shanghai) Co., Ltd.RecruitingMetastatic MelanomaUnited States, Australia
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute AustraliaCompleted
-
Merck Sharp & Dohme LLCCompletedMerkel Cell CarcinomaUnited States, Australia, Canada, France, Italy, New Zealand, Spain, Sweden
-
Ludwig Institute for Cancer ResearchInstitute of Cancer Research, United KingdomCompletedMelanomaUnited Kingdom, Australia, New Zealand
-
University of SydneyMelanoma and Skin Cancer Trials LimitedCompleted
-
Grupo Espanol de Tumores NeuroendocrinosEisai Limited; Experior S.L.CompletedNeuroendocrine TumorsSpain, Italy, Austria, United Kingdom
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMelanoma | MetastasisAustralia
-
Eli Lilly and CompanyCompletedMetastatic MelanomaAustralia, United States
-
Evaxion Biotech A/SNovotech (Australia) Pty LimitedTerminatedMelanoma Stage IV | Melanoma Stage IIIAustralia
-
GlaxoSmithKlineCompleted
-
Olivia Newton-John Cancer Research InstituteBristol-Myers SquibbActive, not recruitingGastrointestinal Cancer | Malignant Female Reproductive System Neoplasm | Neuroendocrine TumoursAustralia
-
EMD Serono Research & Development Institute, Inc.CompletedCarcinoma, Merkel CellUnited States, Spain, Australia, Italy, Germany, France, Japan
-
Novartis PharmaceuticalsTerminatedIslet Cell TumorFrance, Spain, United Kingdom, Belgium, Hungary, Turkey, Canada, Argentina, Sweden, Italy, Thailand, Germany, Netherlands, Brazil, Australia, Japan, United States, Denmark, New Zealand
-
Stemirna TherapeuticsRecruitingSolid TumorAustralia, Austria
-
Melanoma and Skin Cancer Trials LimitedTrans Tasman Radiation Oncology GroupActive, not recruiting
-
Novartis PharmaceuticalsCompletedSymptomatic Refractory Resistant Carcinoid DiseaseUnited Kingdom, Belgium, Italy, Singapore, Austria, France, Israel, Sweden, Germany, Spain, Canada, Argentina, Poland, United States, Brazil, Norway
-
Melanoma Institute AustraliaActive, not recruiting
-
Novartis PharmaceuticalsCompletedWell-differentiated Non-functional NET of Thoracic Origin | Well-differentiated Non-functional NET of Gastrointestinal Origin | Well-differentiated Non-functional NET of Pancreatic Origin | Poorly-differentiated Gastroenteropancreatic Neuroendocrine CarcinomaUnited States, Italy, Spain, Japan, Belgium, Netherlands, Germany, France, Canada, Austria, United Kingdom, Australia
-
Novo Nordisk A/SCompleted
-
Melanoma and Skin Cancer Trials LimitedBristol-Myers Squibb; Amgen; Peter MacCallum Cancer Centre, AustraliaActive, not recruitingMelanoma | Melanoma Stage Iv | Melanoma Stage IiiAustralia
-
Kartos Therapeutics, Inc.RecruitingMerkel Cell CarcinomaUnited States, Netherlands, Korea, Republic of, France, Germany, Spain, Canada, Italy, Australia, Brazil
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruitingMelanoma Stage IvAustralia, Norway
-
ActelionCompleted
-
Ludwig Institute for Cancer ResearchCancer Research Institute, NY, USATerminatedNY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic MelanomaUnresectable or Metastatic MelanomaUnited States, Australia
-
ImmVira Pharma Co. LtdRecruitingMelanoma | Sarcoma | NSCLC | Solid Tumor | HNSCC | Squamous Cell CarcinomaUnited States, Australia
-
AstraZenecaCompletedMelanomaUnited States, Australia, Brazil, United Kingdom, Argentina, Austria, Canada, Denmark, France, Switzerland
-
Piramal Enterprises LimitedCompletedMelanomaAustralia, India, New Zealand
-
Bristol-Myers SquibbTerminatedStudy to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced MelanomaMelanomaFrance, United States, Italy, Germany, Austria